{"title":"阿尔茨海默病:新疗法和生物标志物的作用。","authors":"Kellie Dudash","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Biomarkers have shown promise for identifying people at high risk for Alzheimer's disease. Therapies that address presymptomatic disease are already in development, and MCOs should start thinking about coverage for them.</p>","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"8 1","pages":"22-3"},"PeriodicalIF":0.0000,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086124/pdf/bth08_1p022.pdf","citationCount":"0","resultStr":"{\"title\":\"Alzheimer's disease: new therapies and the role of biomarkers.\",\"authors\":\"Kellie Dudash\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Biomarkers have shown promise for identifying people at high risk for Alzheimer's disease. Therapies that address presymptomatic disease are already in development, and MCOs should start thinking about coverage for them.</p>\",\"PeriodicalId\":89534,\"journal\":{\"name\":\"Biotechnology healthcare\",\"volume\":\"8 1\",\"pages\":\"22-3\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2011-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086124/pdf/bth08_1p022.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biotechnology healthcare\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology healthcare","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Alzheimer's disease: new therapies and the role of biomarkers.
Biomarkers have shown promise for identifying people at high risk for Alzheimer's disease. Therapies that address presymptomatic disease are already in development, and MCOs should start thinking about coverage for them.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
